⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Pomerantz LLP Advises Shareholders of Class Action Filing Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Join Class Action to Recover Losses From MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Alerts Shareholders to Investor Suit Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
MLTX ALERT: Securities Fraud Class Action Launched Against MoonLake Immunotherapeutics - December 15, 2025 Deadline
accessnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics (MLTX)? Contact Levi & Korsinsky to Join Class Action Before December 15, 2025
accessnewswire.com
MLTX
Join Class Action to Recover Losses from MoonLake Immunotherapeutics (MLTX) - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX ALERT: Securities Fraud Class Action Launched Against MoonLake Immunotherapeutics - December 15, 2025 Deadline
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: MoonLake Immunotherapeutics Investors are Encouraged to Act before the Upcoming December 15 Deadline - Contact BFA Law if You Lost Money
accessnewswire.com
MLTX
Your Guide to the MoonLake Immunotherapeutics Lawsuit - A SueWallSt Podcast From Levi & Korsinsky
accessnewswire.com
MLTX